Skip to content
PaperFren

Concept · biology

GWAS

A genome-wide association study (GWAS) scans many genetic variants across the genome for statistical association with a trait. Related tools in this library include polygenic scores built from GWAS weights and Mendelian randomisation that uses genetic instruments (often from GWAS) to probe putative causal links under explicit assumptions.

GWAS hits, polygenic scores, and MR estimates are easy to collapse into “genes cause the trait.” They answer different questions—discovery of associations, prediction accuracy, and instrument-based causal inference—with different failure modes.

Studies

7

Findings

5

5 supporting · 0 challenging · 10 qualifying citations

Open tensions

2

Currently

What we know

  1. Polygenic score accuracy can differ a lot among groups that share a broad ancestry label.
  2. Liver eQTL maps link common variants to expression of disease-relevant metabolic genes.
  3. Rare variants can create synthetic GWAS signals at common markers when clustered.
  4. Large dairy GWAS recover many additive SNP effects, some in genes and some elsewhere.
  5. Mendelian randomisation on gut taxa reports a limited set of microbiome–cancer links.

Largest unresolved question

Human PGS accuracy, liver eQTLs, rare-variant synthetic-signal theory, livestock/plant GWAS, and microbiome–cancer MR all live under a GWAS umbrella, but they answer different estimands. Pooling them as one “GWAS finding” erases species, trait, and method limits.

Common misconceptions

  • If two groups share a continental ancestry label, their polygenic scores should predict equally well.

    Within-ancestry PGS accuracy can still differ sharply with ascertainment and SES-related structure; ancestry labels alone do not guarantee equal performance.

  • Every genome-wide significant SNP marks one common causal variant for the trait.

    Rare variants can create synthetic association at common markers under plausible allele-frequency configurations; functional follow-up is still required.

  • Mendelian randomisation using GWAS instruments proves the biological mechanism from exposure to disease.

    MR supports a directional association under instrument assumptions. The microbiome–cancer MR paper notes unproven experimental pathways, ancestry limits, and coarse taxon resolution.

Related